CSIMarket

Product Service News

Crinetics Pharmaceuticals Releases Early s for ENDO 2024: Revamping Endocrine Disease Therapeutics

May 22, 2024

In a recent announcement, Crinetics Pharmaceuticals, a clinical-stage pharmaceutical company dedicated to addressing endocrine diseases and endocrine-related tumors, informed the public that the late-breaking abstracts for the Endocrine Society s annual meeting (ENDO 2024) have been released earlier than anticipated...

Product Service News

Lenders One's L1 Insurance: Augmenting Insurance Acquisition for Borrowers and Lenders

May 22, 2024

Lenders One Revolutionizes the Insurance Market with L1 Insurance: Enhancing Borrowers Access to Homeowners and Automobile InsuranceIn an exciting development, Lenders One recently announced the launch of L1 Insurance, a groundbreaking platform that aims to transform the way homeowners and automobile insurance is o...

Product Service News

Kratos Defense Maneuvers Through Innovation and Market Complexities'

May 22, 2024

Kratos Defense: Navigating Growth Amidst Integrated Tech Innovations and Market Dynamics By Author Name Kratos Defense and Security Solutions Inc. (KTOS), a pivotal player in defense and security solutions, is demonstrating a mix of strategic advancements and market challenges as it navigates the evolving landscape...

Clinical Study

Potential Breakthrough in Fibromyalgia Treatment: Tonix Pharmaceuticals Reports Positive Results from Phase 3 Clinical Trial

May 22, 2024

Fibromyalgia is a debilitating condition characterized by chronic pain, fatigue, and cognitive difficulties, commonly referred to as brain fog. The search for an effective treatment has proven challenging, with limited options currently available. However, Tonix Pharmaceuticals, a leading biopharmaceutical company, ...

Clinical Study

Promising Advancement in Immuno-Oncology: Indaptus Therapeutics Completes First Multiple-Dose Administration of Decoy20 in Phase 1 Trial'

May 22, 2024

Significant Advancement in Immuno-Oncology: Indaptus Therapeutics Completes First Multiple-Dose Administration of Decoy20 in Phase 1 Trial On May 22, 2024, Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical-stage biotechnology company, announced a major milestone in the development of its investigational thera...

Our most Popular Articles
Business Update

GeoPark Strikes Deal with Vitol, Advances Sustainability Goals for Llanos 34 Block

May 10, 2024

GeoPark Limited, a major independent Latin American oil and gas explorer and operator, recently signed an offtake and prepayment agreement with international energy and commodity firm Vitol. The agreement will permit GeoPark to sell and offer a minimum of 20,000 barrels of oil per day (bopd) of production extracted ...

Business Update

Mattel Films Joins Forces with Universal Pictures and Akiva Goldsman for Highly Anticipated Monster High Feature Film...

June 6, 2024

Mattel Films, Universal Pictures, and Akiva Goldsman to Collaborate on Monster High Live-Action FilmIn an exciting partnership, Mattel Films has joined forces with Universal Pictures and Academy Award-winning producer/screenwriter Akiva Goldsman to create a live-action theatrical film based on the popular fashion do...

Business Update

Kezar Life Sciences: Strategic Inducement and Robust Q1 2024 Financial Performance

June 9, 2024

Kezar Life Sciences: Strategic Inducement Grant and Q1 2024 Financial Highlights Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company specializing in innovative small molecule therapeutics to address substantial unmet needs in immune-mediated diseases and cancer, continues to make signific...

Company News
Product Service News

Lenders One's L1 Insurance: Augmenting Insurance Acquisition for Borrowers and Lenders

May 22, 2024

Lenders One Revolutionizes the Insurance Market with L1 Insurance: Enhancing Borrowers Access to Homeowners and Automobile InsuranceIn an exciting development, Lenders One recently announced the launch of L1 Insurance, a groundbreaking platform that aims to transform the way homeowners and automobile insurance is o...

Product Service News

Kratos Defense Maneuvers Through Innovation and Market Complexities'

May 22, 2024

Kratos Defense: Navigating Growth Amidst Integrated Tech Innovations and Market Dynamics By Author Name Kratos Defense and Security Solutions Inc. (KTOS), a pivotal player in defense and security solutions, is demonstrating a mix of strategic advancements and market challenges as it navigates the evolving landscape...

Product Service News

Microchip Technology Incorporated Faces Revenue Decline in 4Q 2023 Despite Innovative BlueSky Firewall Technology

May 22, 2024

Microchip Technology Incorporated, a leading provider of semiconductor solutions, has recently released the TimeProvider 4100 Grandmaster Version 2.4 Firmware. This powerful upgrade not only adds crucial IEEE 1588 standard profiles to meet the synchronization requirements of power and 5G private networks but also in...

Company News
Clinical Study

Barinthus Biotherapeutics Announces Groundbreaking Clinical Data for VTP-300 at EASL Congress 2024

May 22, 2024
Company News
Clinical Study

BioVie's Bezisterim Demonstrates Promising Potential in Alleviating Parkinson's Disease Symptoms, While Biovie Inc Sees Growth in Corporate Revenue

May 22, 2024
Company News
Clinical Study

Avadel Pharmaceuticals Unveils New LUMRYZ Data at SLEEP 2024, Highlighting Patient Satisfaction and Clinical Efficacy

May 22, 2024
More Company News
Business Update

Scholar Rock Initiates Phase 2 Trial for Apitegromab in Obesity, Unveils Promising Preclinical Data for SRK-439

May 22, 2024
Financing Agreement

Perma-Fix Environmental Services Inc. Resilient in Face of Borrowings and High Leverage Ratios

May 22, 2024
Financing Agreement

Agrify Corporation's Debt-to-Equity Conversion Sets the Stage for Enhanced Financial Stability and Growth

May 22, 2024
Clinical Study

MiNK Therapeutics' Clinical Data Reveals Promising Results for AgenT-797 in Severe Acute Respiratory Distress Syndrome (ARDS) and Refractory Gastric Cancer Therapy

May 22, 2024
Business Update

Tutor Perini Secures $228.6M FLL Airport Project, Leads Q1 2024 Revenue Growth by 35%

May 22, 2024
Business Update

Navigating the Tide: TELUS International and eGain Forge Partnership Amidst Revenue Challenges and Profit Gains'

May 22, 2024
Business Update

Travel Green: ChargePoint and Airbnb's Strategic Alliance to Transform Electric Vehicle Charging for Modern Travelers'

May 22, 2024
Business Update

AECOM's Vision for Sustainable Growth: Expanding Ontario's Clarkson Water Resource Recovery Facility

May 22, 2024
Announcement

Akoustis Technologies Inc Breaks New Ground with Enhanced XBAW Designs and Impressive Sales Growth

May 22, 2024
Clinical Study

Entero Therapeutics Unveils Promising Phase 3 Treatment for Celiac Disease at BIO International Convention 2024

May 22, 2024
Related News
Clinical Study

New Breakthroughs in Hepatitis C Virus Treatment: A Potential Best-in-Class Combination Therapy

Product Service News

Parsons Selected For LAWAs Capital Improvement Program MATOC

Stocks
Product Service News

G1 Therapeutics and Deimos Biosciences Strike Global Licensing Agreement for Lerociclib to Uphold Radioprotective Treatments

Announcement

Mesa Laboratories, Inc. Postpones Earnings Announcement and Highlights Commitment to Responsible Business Practices in New ESG Program Brochure

Product Service News

Fortuna’s Yaramoko Mine Achieves One-Million-Ounce Gold Milestone'

Business News
Clinical Study

Potential Breakthrough in Fibromyalgia Treatment: Tonix Pharmaceuticals Reports Positive Results from Phase 3 Clinical Trial

Fibromyalgia is a debilitating condition characterized by chronic pain, fatigue, and cognitive difficulties, commonly referred to as brain fog. The search for an effective treatment has proven challenging, with limited options currently available. However, Tonix Pharmaceuticals, a leading biopharmaceutical company, ...

Clinical Study

Promising Advancement in Immuno-Oncology: Indaptus Therapeutics Completes First Multiple-Dose Administration of Decoy20 in Phase 1 Trial'

Significant Advancement in Immuno-Oncology: Indaptus Therapeutics Completes First Multiple-Dose Administration of Decoy20 in Phase 1 Trial On May 22, 2024, Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical-stage biotechnology company, announced a major milestone in the development of its investigational thera...

Clinical Study

Adlai Nortye Launches Phase II ARTEMIS Trial to Enhance Rectal Cancer Treatment with Palupiprant*

Adlai Nortye Initiates Phase II Clinical Trial of Palupiprant for Locally Advanced Rectal Cancer Treatment Singapore, North Brunswick, NJ, and Hangzhou, China, May 22, 2024 Adlai Nortye Ltd. (NASDAQ: ANL), a clinical-stage biotechnology firm specializing in cutting-edge cancer treatments, is pleased to announce the ...

Product Service News

for This *Dayforce Introduces Flex Work: A Revolutionary Solution to Maximize the Potential of the Contingent Workforce*

Dayforce Delivers Flex Work, Unlocking the Value of the Contingent WorkforceIn today s rapidly evolving labor market, organizations are increasingly leveraging the contingent workforce to drive agility and maintain a competitive edge. Recognizing this trend, Dayforce has introduced its newest innovation, Flex Work....

Product Service News

Crinetics Pharmaceuticals Releases Early s for ENDO 2024: Revamping Endocrine Disease Therapeutics

In a recent announcement, Crinetics Pharmaceuticals, a clinical-stage pharmaceutical company dedicated to addressing endocrine diseases and endocrine-related tumors, informed the public that the late-breaking abstracts for the Endocrine Society s annual meeting (ENDO 2024) have been released earlier than anticipated...

Our Most Popular Articles
Business Update

GeoPark Strikes Deal with Vitol, Advances Sustainability Goals for Llanos 34 Block

GeoPark Limited, a major independent Latin American oil and gas explorer and operator, recently signed an offtake and prepayment agreement with international energy and commodity firm Vitol. The agreement will permit GeoPark to sell and offer a minimum of 20,000 barrels of oil per day (bopd) of production extracted ...

Business Update

Mattel Films Joins Forces with Universal Pictures and Akiva Goldsman for Highly Anticipated Monster High Feature Film...

Mattel Films, Universal Pictures, and Akiva Goldsman to Collaborate on Monster High Live-Action FilmIn an exciting partnership, Mattel Films has joined forces with Universal Pictures and Academy Award-winning producer/screenwriter Akiva Goldsman to create a live-action theatrical film based on the popular fashion do...

Business Update

Kezar Life Sciences: Strategic Inducement and Robust Q1 2024 Financial Performance

Kezar Life Sciences: Strategic Inducement Grant and Q1 2024 Financial Highlights Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company specializing in innovative small molecule therapeutics to address substantial unmet needs in immune-mediated diseases and cancer, continues to make signific...

More News
Product Service News

Lenders One's L1 Insurance: Augmenting Insurance Acquisition for Borrowers and Lenders

Lenders One Revolutionizes the Insurance Market with L1 Insurance: Enhancing Borrowers Access to Homeowners and Automobile InsuranceIn an exciting development, Lenders One recently announced the launch of L1 Insurance, a groundbreaking platform that aims to transform the way homeowners and automobile insurance is o...

Product Service News

Kratos Defense Maneuvers Through Innovation and Market Complexities'

Kratos Defense: Navigating Growth Amidst Integrated Tech Innovations and Market Dynamics By Author Name Kratos Defense and Security Solutions Inc. (KTOS), a pivotal player in defense and security solutions, is demonstrating a mix of strategic advancements and market challenges as it navigates the evolving landscape...

Product Service News

Microchip Technology Incorporated Faces Revenue Decline in 4Q 2023 Despite Innovative BlueSky Firewall Technology

Microchip Technology Incorporated, a leading provider of semiconductor solutions, has recently released the TimeProvider 4100 Grandmaster Version 2.4 Firmware. This powerful upgrade not only adds crucial IEEE 1588 standard profiles to meet the synchronization requirements of power and 5G private networks but also in...

Clinical Study

Barinthus Biotherapeutics Announces Groundbreaking Clinical Data for VTP-300 at EASL Congress 2024

In a groundbreaking development, Barinthus Biotherapeutics plc (NASDAQ: BRNS) is set to present crucial clinical data updates at the highly anticipated European Association for the Study of the Liver (EASL) Congress, taking place in Milan, Italy from June 5 to 8, 2024. The prestigious event will showcase the cutting...

Clinical Study

BioVie's Bezisterim Demonstrates Promising Potential in Alleviating Parkinson's Disease Symptoms, While Biovie Inc Sees Growth in Corporate Revenue

BioVie s Bezisterim Demonstrates Potential Improvements in Sleep/Fatigue and Restless Leg Symptoms for Parkinson s Disease PatientsFull Dataset from Phase 2a trial in Parkinson s Disease suggest patients treated with bezisterim experienced significant improvements in both non-motor symptoms and motor control while p...

Clinical Study

Avadel Pharmaceuticals Unveils New LUMRYZ Data at SLEEP 2024, Highlighting Patient Satisfaction and Clinical Efficacy

At the prestigious SLEEP 2024 Conference, Avadel Pharmaceuticals unveiled compelling new insights related to their flagship extended-release oral suspension drug, LUMRYZ (sodium oxybate). This year, an impressive 11 accepted abstracts presented at the conference reinforced the clinical benefits, patient satisfaction...

Business Update

Scholar Rock Initiates Phase 2 Trial for Apitegromab in Obesity, Unveils Promising Preclinical Data for SRK-439

Scholar Rock, a late-stage biopharmaceutical company specializing in research and development of innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other protein growth factor-related diseases, has recently announced the commencement of the Phase 2 EMBRAZE proof-of-concept trial....

Financing Agreement

Perma-Fix Environmental Services Inc. Resilient in Face of Borrowings and High Leverage Ratios



In a recent press release, Perma-Fix Environmental Services Inc. (Perma-Fix) has announced a definitive agreement for the issuance and sale of 2,051,282 shares of its common stock at an offering price of $9.75 per share. This move showcases the company s determination to strengthen its financial position a...

Financing Agreement

Agrify Corporation's Debt-to-Equity Conversion Sets the Stage for Enhanced Financial Stability and Growth



In an announcement that highlights Agrify Corporation s commitment to strengthening its financial position, the company recently revealed a debt-to-equity conversion worth approximately $13.8 million. This news comes in the backdrop of a challenging quarter for the company, marked by a notable increase in ...

Clinical Study

MiNK Therapeutics' Clinical Data Reveals Promising Results for AgenT-797 in Severe Acute Respiratory Distress Syndrome (ARDS) and Refractory Gastric Cancer Therapy

MiNK Therapeutics Presents Promising Clinical Activity of AgenT-797 in Severe Acute Respiratory Distress Syndrome (ARDS) and Gastric Cancer PatientsNew York, May 22, 2024 - MiNK Therapeutics, Inc. (NASDAQ: INKT), a leading clinical-stage biopharmaceutical company specializing in allogeneic, off-the-shelf, invariant ...

Business Update

Tutor Perini Secures $228.6M FLL Airport Project, Leads Q1 2024 Revenue Growth by 35%

LOS ANGELES Tutor Perini Corporation (NYSE: TPC), a renowned name in civil, building, and specialty construction, has fortified its impressive portfolio with a new achievement. Its subsidiary, Tutor Perini Building Corp., has been awarded a significant contract valued at approximately $228.6 million. This contract...

Business Update

Navigating the Tide: TELUS International and eGain Forge Partnership Amidst Revenue Challenges and Profit Gains'

TELUS International Boosts Service Offering with eGain Partnership: Navigating Revenue Challenges and Profit Gains In an era where customer experience (CX) can make or break a business, cutting-edge technology and AI functionalities are becoming indispensable tools for contact centers. Vancouver-based TELUS Internat...

Business Update

Travel Green: ChargePoint and Airbnb's Strategic Alliance to Transform Electric Vehicle Charging for Modern Travelers'

ChargePoint and Airbnb Join Forces to Revolutionize EV Charging for Travelers CAMPBELL, Calif. ChargePoint (NYSE: CHPT), a pioneering entity in the realm of networked charging solutions for electric vehicles (EVs), has amalgamated efforts with sharing economy giant, Airbnb Inc. (NASDAQ: ABNB). Today, the dynamic duo unveiled a groundbreaking partnership aimed at revolutionizing the EV charging experience for Airbnb guests across the United States. By simplifying the process for Airbnb hosts to install EV chargers at their properties, the partnership promises to substantially expand the accessibility of EV charging solutions nationwide. A Powerful Union to Address a Growing Need The landscape of transportation is rapidly evolving, with a surging number of consumers transitioning to electric vehicles due to their environmental benefits and long-term cost savings. This shift, however, has surfaced a crucial requirement: the easy accessibility to reliable charging infrastructure. Recognizing this pressing demand, ChargePoint and Airbnb have jointly engineered a seamless solution designed to make EV travel more convenient and dependable for the modern traveler.“We are thrilled to embark on this partnership with Airbnb to expand EV charging infrastructure where it’s needed most at the spots where people travel and stay,” said a ChargePoint spokesperson. By combining our networked charging solutions with the vast reach of Airbnb s host community, we can offer a robust and reliable charging experience right where travelers are encouraging more people to consider going electric.” Empowering Hosts, Revolutionizing Travel One of the standout features of this initiative is its focus on Airbnb hosts. ChargePoint and Airbnb are committed to making the installation of EV chargers as straightforward and efficient as possible. Through this partnership, Airbnb hosts will receive preferential access to ChargePoint s extensive product range, including the latest in technologically advanced home EV charging stations.

Business Update

AECOM's Vision for Sustainable Growth: Expanding Ontario's Clarkson Water Resource Recovery Facility

Expanding Clarkson Water Resource Recovery Facility: AECOM s Commitment to Ontario s Growing PopulationAECOM, the world s trusted infrastructure consulting firm, has been chosen by the Regional Municipality of Peel (Peel Region) to provide design and engineering services for the expansion of the Clarkson Water Resou...

Announcement

Akoustis Technologies Inc Breaks New Ground with Enhanced XBAW Designs and Impressive Sales Growth

Akoustis Technologies, Inc. has announced the completion of its XBAW design updates across its product portfolio, marking a significant milestone for the company. As an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, Akoustis ...

Clinical Study

Entero Therapeutics Unveils Promising Phase 3 Treatment for Celiac Disease at BIO International Convention 2024

Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention: Advancements in Celiac Disease TreatmentEntero Therapeutics, a leading late clinical-stage biotechnology company, is gearing up to present a highly anticipated corporate update at the prestigious 2024 BIO International Convention. ...



Previous News 1. Page 466. Page 467. Page 468. Page .... 515. Page .... 565. Page NEXT 
Previous News


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.